Wednesday, 30 September 2026 · New York Edition · 09:00 New York

Bonds are cracking. Equities haven't priced it — TLT is 1% off its low.

Signals

Global bonds

US and Japanese yields keep climbing even as WTI sits near $90 after a 4.4% one-day drop in USO, which retires the usual oil-to-inflation-to-yields chain. Nikkei's read: fiscal risk and Middle East uncertainty now dominate, forcing central banks to walk a tightrope. WSJ's Spencer Jakab takes the other side — after wrecking retirement funds, bonds deserve a second chance on higher starting yields — and Jason Zweig uses the same paper to warn against leveraged bond products. TLT closed 1% off its 52-week low; TMF is down 8.3% on the week.

TBT

Buy Ultrashort 20Y Treasuries — Nikkei's oil-decoupling argument makes the short-duration expression the cleaner one, but TBT is 1% below its 52-week high and up 5.9% on the week — the easy part of this move is gone.

$42.03 +1.20%
GLD

Buy Gold — Nikkei ties fiscal worry plus Middle East uncertainty and sticky inflation to gold support; GLD rose 1.3% last session but is still 25% below its 52-week high.

$382.9 +1.32%
TMF

Sell 3x leveraged long bonds — WSJ's Zweig column flags leveraged ETFs as products to understand before holding; TMF is down 8.3% on the week and 29.7% YTD with decay doing the work.

$26.07 -1.59%
TLT

Watch Long-duration Treasuries — Nikkei sees persistent yield pressure from fiscal risk while WSJ's Jakab argues higher starting yields make the second chance real — with TLT 1% off its 52-week low, both sides are live and the press is genuinely split.

$78.23 -0.50%

Bank deposits

WSJ's Ben Glickman reframes deposit stickiness as a technology problem rather than a loyalty one: AI agents will automatically shop customer cash into higher-rate accounts, attacking the cheap funding that JPMorgan, Wells Fargo and Bank of America's margins depend on. Digital banks paying up for deposits — SoFi — are the natural destination. There's no deposit-beta estimate, no margin impact and no timeline in the piece. This is a thesis, not a model. The first real trace shows up in net interest margin guidance in the Q3 prints.

SOFI

Buy SoFi Technologies — SoFi is the natural destination for rate-shopping AI agents, but at 19.3x forward and 51% below its 52-week high after a 42% YTD drawdown it's a rich way to buy a thematic shift.

$15.91 -0.13%
JPM

Sell JPMorgan — WSJ's Glickman argues AI agents erode the sticky low-cost deposits underpinning JPMorgan's advantage; the stock is 9% below its 52-week high on 13.4x forward and isn't pricing deposit flight.

$335.0 -0.48%
WFC

Sell Wells Fargo — Wells Fargo is the most deposit-funded of the majors so higher deposit costs hit net interest margin directly; it trades 10.1x forward, 15.5% lower YTD — cheap for a reason if this lands.

$80.48 -0.41%

Regional banks

FT's column argues bank runs are almost always justified — depositors who leave are reading the balance sheet correctly, not panicking — a direct shot at the regulatory framing of runs as irrational contagion. It names no banks, no datasets and no dated evidence, so treat it as a thesis rather than a signal. The read-across that survives: uninsured-deposit-funded regionals carry a permanent tail risk that never fully prices out. KRE sits 11% below its 52-week high and 21% above its low.

KRE

Sell Regional banks — FT's argument that runs are usually rational keeps a permanent tail risk on uninsured-deposit-funded regionals; KRE fell 1.0% last session and sits 11% below its 52-week high, so none of that risk is priced.

$69.83 -1.02%

Biotech

Citi published a call for roughly 60% downside in Moderna after the stock's run since mid-August, and CNBC led with the contrast rather than the substance. The excerpt gives direction without a price target, valuation multiple or catalyst breakdown, which makes it hard to underwrite even though fading a two-month momentum run is a defensible instinct. MRNA is 3% below its 52-week high, up 11.7% on the week and up 559% YTD. Momentum this extended is exactly when sell-side target cuts bite.

MRNA

Sell Moderna — Citi's target implies roughly 60% downside after an 11.7% weekly run; MRNA sits 3% below its 52-week high and 559% higher YTD, so the position is early if momentum doesn't break.

“Moderna has been on a tear since mid-August. Citi now sees it plunging 60%”

$203.5 +3.13%

AI supply chain

Two weeks after Anthropic's Dario Amodei spooked AI names with slowdown talk, suppliers gathered at a Silicon Valley infrastructure summit and said order books are bursting and production is running flat out. Broadcom and Toppan opened Singapore's first advanced chip substrate plant — a dated, physical datapoint rather than a sentiment read. The bear case survives in the financing layer: The Information reports Nscale pitching a $35bn IPO on data center capacity it hasn't built. Vendor-conference optimism is self-interested; Nscale is the credibility test.

NVDA

Buy Nvidia — Nikkei's supplier reporting points to continued accelerator demand despite the Amodei selloff; NVDA is 4% below its 52-week high on 14.5x forward after a 20% YTD run.

$227.2 -0.72%
AVGO

Buy Broadcom — Broadcom is named with Toppan in Singapore's first advanced substrate plant — a concrete capex commitment; the stock is 28% below its 52-week high on 18.3x forward, so part of the AI premium has already come out.

$355.1 +1.58%
VRT

Buy Vertiv — Power and cooling orders only exist if these builds get financed and finished; Vertiv is up 41% YTD and 27.2x forward, which already prices much of the buildout.

$248.3 +1.76%
CORZ

Sell Core Scientific — The Information's Nscale report re-prices listed operators with unbuilt capacity; Core Scientific is 47% below its 52-week high and down 9.9% on the week — the market has started asking.

$16.31 -1.27%

OpenAI funding

OpenAI is in early talks to raise roughly $30bn at a $1.4tn valuation after delaying its IPO — The Information had it first and CoinDesk picked it up. Every dollar raised eventually becomes compute orders, so the read-through matters more than the round itself. Microsoft marks its stake up and hosts the workloads, Oracle has committed data center capacity, and AMD is one of the few credible second sources for accelerators. 'Early talks' means terms can move, and the company has confirmed nothing.

MSFT

Buy Microsoft — Two sources report the OpenAI round; Microsoft is the largest backer and cloud host, and the stock sits 8% below its 52-week high on 21.5x forward earnings.

$509.0 -0.05%
ORCL

Buy Oracle — Oracle has committed data center capacity to OpenAI; the stock jumped 3.9% last session but is still 57% below its 52-week high and down 29.6% YTD as the market reprices its AI backlog.

$137.8 +3.91%
AMD

Buy AMD — A cash-rich OpenAI is one of the few buyers able to fund a real second accelerator supplier; AMD is 5% below its 52-week high but trades at 39x forward after a 172% YTD run.

$607.6 -0.05%

Japan AI parts

TDK and Taiyo Yuden agreed Tuesday to jointly develop next-generation AI components, with a capital alliance on the table — a step beyond the usual supply agreement. Both are seeing AI-driven capacitor demand, and both are losing global share to Chinese and Taiwanese rivals, which is the reason to combine. The capital tie-up is the upside optionality a plain technology partnership wouldn't carry. No terms, no timeline, and no confirmation the stake actually gets taken.

6762.T

Buy TDK — Nikkei names TDK as lead partner in the AI component alliance, with a possible capital tie-up on the table beyond the development agreement.

6976.T

Buy Taiyo Yuden — Taiyo Yuden is the other named partner and the possible capital alliance gives the shares a second leg beyond AI capacitor demand.

Taiwan defense

Taiwan has ordered dozens of sea drones, pairing domestic shipbuilding with US software — the SeaShark 800, built by Thunder Tiger. The target is navy and coast guard procurement, a new revenue line for Taiwanese industrials that sit under permanent China risk. Politics is the wildcard: the opposition blocked Lai's special drone budget and passed an alternative, so the procurement path isn't clean. EWT is 2% below its 52-week high and up 76% YTD; ITA is 18% below its high and down 5.7% YTD.

ITA

Buy US aerospace and defense — US software and tech suppliers to Taiwan's drone program sit inside the US defense complex, but ITA is 18% below its 52-week high and down 5.7% YTD with the drone budget fight capping the near-term read.

$209.3 +0.02%
EWT

Hold Taiwan equities — Defense procurement is a new revenue line for Taiwanese industrials, but EWT trades 2% below its 52-week high after a 76% YTD run — the China discount is already gone.

$114.1 -0.05%

Rare earths

More than half of Japan's rare earth imports still come from China, and in some sectors Tokyo's import dependence on Beijing has grown despite years of diplomatic friction — Priyanka Kishore's Nikkei column puts a number on what derisking rhetoric obscures. Southeast Asia gets the cautionary case. The tradable expression is the scarcity premium in Western rare earth names, not a Japan-China decoupling trade, because there isn't one. REMX is 42% below its 52-week high and down 5.8% on the week.

REMX

Buy Rare earth and strategic metals — Nikkei quantifies persistent Chinese dominance in rare earth supply, supporting the scarcity case; REMX is 42% below its 52-week high and down 5.8% on the week, so the trade is out of favour.

$64.79 +0.50%
FXI

Hold China large caps — China keeps leverage over Japan through rare earth and component supply channels; FXI is 19% below its 52-week high and 15% lower YTD at 9x trailing earnings.

$33.86 -0.91%

Boeing orders

Bangladesh signed billions in US purchases — Boeing aircraft, LNG and grains — under a February trade pact, but its garment exports to the US fell 7.55% year-on-year from February to July and the agreement still isn't implemented. Nikkei's story is the asymmetry: buying one way, no export benefit the other. Boeing gets the order book, which is the only clearly tradable piece. BA is 26% below its 52-week high, up 1.8% last session but down 6.1% on the week.

BA

Buy Boeing — Nikkei confirms billions in Boeing aircraft orders inside Bangladesh's US purchasing spree, but the pact remains unimplemented and BA sits 26% below its 52-week high on 45.9x forward earnings.

$187.7 +1.78%

Most original take

<name>Anita Ramaswamy</name> · The Information · 29 Sept 2026

How Nscale’s Unbuilt Data Centers Undercut Its $35 Billion IPO Pitch

Nscale is pitching a $35bn IPO valuation on data center capacity that mostly doesn't exist yet. The Information's read is that the pitch runs well ahead of the build, and the gap matters because neocloud economics depend on power, cooling and shell being in the ground before the GPUs arrive. If a flagship neocloud IPO can't clear that bar, the marginal buyer of AI hardware gets harder to finance, and listed operators like Core Scientific get repriced first.

Read original ↗

Our view

Today's signals are a duration problem wearing several costumes. TLT closed 1% off its 52-week low and TMF — the three-times leveraged version — is down 8.3% on the week and 29.7% YTD, while SPY sits 2% below its own high. That divergence is the day: yields are rising while WTI falls to roughly $90 after a 4.4% one-day drop in USO, which breaks the oil-drives-inflation-drives-yields chain desks have leaned on for two years. Nikkei's read is that fiscal risk and Middle East uncertainty now dominate the oil signal. If that's right, you can't hedge a bond book with commodities and you can't read the curve off crude. The second thread — OpenAI's $30bn at $1.4tn, Broadcom's Singapore substrate plant, Nscale's unbuilt campuses — is the same question from the equity side: does the marginal dollar of AI capex keep arriving? Add WSJ's argument that AI agents will shop deposits out of JPMorgan and Wells Fargo's cheapest funding, and money is moving on every page. Only the direction differs.

The case against our read is positioning. TLT sitting 1% above its 52-week low while TBT sits 1% below its high is the most one-sided trade in the book, and the same fact produces the opposite conclusion: WSJ's Spencer Jakab argues bonds deserve a second chance precisely because starting yields are finally decent. High-yield credit sides with the bears — HYG is pinned at the bottom of its 52-week range while equities are near highs — but a dovish surprise on the front end, or one soft inflation print, forces a violent unwind of crowded duration shorts and hands the AI trade a valuation tailwind it hasn't earned. Australia hiking to a 15-year high is the reminder that global tightening isn't uniform, and that matters for the dollar leg of every one of these trades.

What's missing: nobody is covering the funding side of Japan's yield rise. Japanese and US yields climbing together raises the marginal cost of capital for the world's largest creditor, and yen-funded carry is the actual transmission channel into US credit spreads. Also absent is any work on what a US diesel export ban would do to refining margins and freight costs — that's being filed as an energy story when it's really a transport-inflation story with a longer tail.

The cleanest expression isn't a single ticker. With long bonds at an extreme, AI capex genuinely contested, and single-name vol elevated — Citi's 60% downside call on Moderna lands after a 559% YTD run — index-level positioning is the wrong instrument. We'd rather own dispersion and short-dated vol into October than a directional view on the S&P from 2% below its high.

Yesterday's signals, today

From the New York Edition on 29 Sept 2026 — 5/8 signals moved in the predicted direction.

Share this edition